REMINDER: Cornerstone Therapeutics to Host First Quarter 2013 Conference Call

REMINDER: Cornerstone Therapeutics to Host First Quarter 2013 Conference Call

ID: 257530

(firmenpresse) - CARY, NC -- (Marketwired) -- 05/08/13 -- Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Thursday, May 9, 2013, to discuss its financial results for the first quarter of 2013 ended March 31, 2013. Financial results are expected to be released before the open of the U.S. financial markets on Thursday, May 9, 2013.

To participate in the live conference call, please dial 888-523-1228 (U.S. callers) or 719-325-2432 (international callers), and provide passcode 8910700. A live webcast of the call will also be available through the of the Company's website. Please allow extra time prior to the webcast to register, download and install any necessary audio software.

The conference call and the webcast will be archived for 30 days. The telephone replay of the call will be available approximately two hours after completion of the call by dialing 888-203-1112 (U.S. callers) or 719-457-0820 (international callers), and providing passcode 8910700.



Cornerstone Therapeutics Inc. (NASDAQ: CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets. Key elements of the Company's strategy are to focus its commercial and development efforts in the hospital and adjacent specialty product sector within the U.S. pharmaceutical marketplace; continue to seek out opportunities to acquire companies, marketed or registration-stage products and late-stage development products that fit within the Company's focus areas; and generate revenues by marketing approved generic products through the Company's wholly-owned subsidiary, Aristos Pharmaceuticals, Inc. For more information, visit .



Investor Relations Contact:
Josh Franklin
Vice President, Strategy and Business Development
+1-919-678-6520


Media Relations Contact:
FleishmanHillard




Andrea Moody
+1-919-457-0743


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Russell J. Howard to Join Prima BioMed's Board of Directors Portola Announces Its Factor Xa Inhibitor Antidote PRT4445 Produces Rapid, Sustained and Dose-Related Reversal of the Anticoagulant Activity of Eliquis(R) in Phase 2 Study
Bereitgestellt von Benutzer: Marketwired
Datum: 08.05.2013 - 12:00 Uhr
Sprache: Deutsch
News-ID 257530
Anzahl Zeichen: 0

contact information:
Town:

CARY, NC



Kategorie:

Biotech



Diese Pressemitteilung wurde bisher 118 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"REMINDER: Cornerstone Therapeutics to Host First Quarter 2013 Conference Call"
steht unter der journalistisch-redaktionellen Verantwortung von

Cornerstone Therapeutics (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Cornerstone Therapeutics



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z